Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Launay

Showing results (111-120 of 307) with videos related to

Pageof 31
Sort By:
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Autoimmunity Reviews|August 26, 2014
Systemic sclerosis and prevalence of monoclonal immunoglobulinSalim Trad, Audrey Nosbaum, Lucile Musset, et al.
European Radiology|July 26, 2022
Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patientsAntoine Dupont, Vincent Koether, Julien Labreuche, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
Arthritis and Rheumatism|October 2, 2007
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approachDidier Lefranc, David Launay, Sylvain Dubucquoi, et al.
Rheumatology (Oxford, England)|December 23, 2023
Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisisAurore Collet, Sebastien Sanges, Amjad Ghulam, et al.
Frontiers in Immunology|March 2, 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committeeMauro Cancian, Teresa Caballero, Isabelle Boccon-Gibod, et al.
Arthritis Research & Therapy|May 1, 2026
Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosisMarguerite Merger, Jonathan Giovannelli, David Launay, et al.
Clinical and Experimental Rheumatology|June 6, 2023
Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosisCecile M Yelnik, Marc Lambert, Elodie Drumez, et al.
Pageof 31

Showing results (111-120 of 307) with videos related to

Sort By:
Pageof 31
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Autoimmunity Reviews|August 26, 2014
Systemic sclerosis and prevalence of monoclonal immunoglobulinSalim Trad, Audrey Nosbaum, Lucile Musset, et al.
European Radiology|July 26, 2022
Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patientsAntoine Dupont, Vincent Koether, Julien Labreuche, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
Arthritis and Rheumatism|October 2, 2007
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approachDidier Lefranc, David Launay, Sylvain Dubucquoi, et al.
Rheumatology (Oxford, England)|December 23, 2023
Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisisAurore Collet, Sebastien Sanges, Amjad Ghulam, et al.
Frontiers in Immunology|March 2, 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committeeMauro Cancian, Teresa Caballero, Isabelle Boccon-Gibod, et al.
Arthritis Research & Therapy|May 1, 2026
Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosisMarguerite Merger, Jonathan Giovannelli, David Launay, et al.
Clinical and Experimental Rheumatology|June 6, 2023
Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosisCecile M Yelnik, Marc Lambert, Elodie Drumez, et al.
Pageof 31